largely because the genes coding for MBLs can be disseminated horizontally among Gram-negative bacteria, including major pathogens for humans and animals. 1 IMP-type carbapenemases represent one of the clinically most relevant MBL groups in terms of epidemiological dissemination; they have been reported worldwide in Pseudomonas aeruginosa, several members of the family Enterobacteriaceae and Acinetobacter species of human clinical origin. 1 So far, bacterial isolates from non-human sources that harbour bla IMP genes have only been reported from river water in Tunisia (Klebsiella pneumoniae) and from sewage in Germany (identified by PCR without exact knowledge of the bacterial host). 2 Here, we report the isolation of a bla IMP-45 -carrying multidrug-resistant P. aeruginosa isolate from a dog in China during a routine surveillance study of carbapenem-resistant Gram-negative bacteria from pet animals in 2013. Using a Mueller-Hinton agar plate containing 100 mg/L vancomycin and 2 mg/L meropenem, isolate M140A was obtained from the anal swab of a healthy 3-month-old female German Shepherd dog admitted in June 2013 to the Animal Teaching Hospital of the China Agricultural University in Beijing, China, for routine vaccination against canine parvovirus infection. The isolate was identified as P. aeruginosa by both the API 20NE system (bioMérieux, Marcy-l'Étoile, France) and 16S rDNA sequencing as described previously. 3 MICs of various antimicrobial agents were determined by broth microdilution and interpreted using the clinical breakpoints given in CLSI document M100-S24. The imipenem-EDTA double-disc synergy test and Etest using MBL strips (bioMé rieux, Craponne, France) confirmed that this isolate produced an MBL. The presence of known mobile MBL-encoding genes for NDM-, VIM-, SIM-, SPM-, GIM-, AIM-and DIM-type b-lactamases was investigated using previously described PCR assays. 3 Only bla IMP was detected using the primers F 5
′ -GAAGGYGTTTATGTTCATAC-3 ′ and R 5 ′ -GTAMGTTTCAAGAGTGA TGC-3 ′ . The complete bla IMP gene was obtained by primer walking using primers located inside the bla IMP gene. 3 The resulting sequence contained an open reading frame of 738 bp, which showed 99.9% nucleotide sequence identity (737/738 bp, A640G nucleotide substitution) to the bla IMP-9 gene from plasmid pOZ176 (GenBank accession no. NC_022344) of a clinical P. aeruginosa of human origin isolated during a multicentre surveillance study in Guangzhou, China. 5 The corresponding 245 amino acid protein differed from that of IMP-9 by a single amino acid exchange (Gly214Ser). The bla IMP gene from P. aeruginosa M140A showed 100% nucleotide sequence identity to a bla IMP-45 gene of not further specified origin, listed in the database of the nomenclature centre (http://www.lahey.org/studies). S1 nuclease PFGE and Southern blot analysis indicated that the bla IMP-45 gene was located in the chromosomal DNA ( Figure S1 , available as Supplementary data at JAC Online).
Multilocus sequence typing (MLST) of isolate M140A was performed according to published protocols (http://pubmlst.org/ paeruginosa). Comparison with the allelic profiles available in the aforementioned MLST database identified isolate M140A as sequence type (ST) 308. This ST has been associated with multidrug-resistant P. aeruginosa isolates carrying different types of carbapenemases, including IMP-13-producing isolates from patients in France. 6 The flanking regions of the bla IMP-45 gene were sequenced using a modified random primer walking strategy, 3 resulting in a 10 991 bp fragment (GenBank accession no. KJ510410; Figure 1 ). The bla IMP-45 gene was located in a class 1 integron as part of a resistance gene cassette array consisting of aacA4-bla IMP-45 -bla OXA-1 -catB3, which confers resistance to gentamicin and amikacin, carbapenems, ampicillin and chloramphenicol, respectively. The 6149 bp segment that comprised the bla IMP-45 -carrying class 1 integron showed 100% nucleotide sequence identity to the corresponding segment of a plasmid from the human clinical P. aeruginosa strain B3 isolated in Guangzhou (accession no. EU588392). Moreover, the 3 ′ conserved region of the integron (qacED1 and sul1) and the upstream region of the bla IMP-45 gene including aacA4, the 5 ′ conserved segment (intI1) of the integron and a Tn1403-like transposon (tnpR and tnpA) exhibited 99.9% (2348/2349) and 100% (5728/5728) nucleotide sequence identity, respectively, to corresponding regions of plasmid pOZ176 from a clinical P. aeruginosa isolate also found in Guangzhou (Figure 1) .
In companion animals, carbapenemase-producing Escherichia coli carrying bla NDM-1 or bla OXA-48 and K. pneumoniae carrying bla OXA-48 have been isolated from clinical infections. 7, 8 The future will show whether these observations represent 'the tip of the iceberg' or rare accidental findings. 8, 9 In the present case, the frequency of identification of P. aeruginosa ST308 from human clinical samples as well as the high level of similarity of the genetic environment of bla IMP-45 from canine P. aeruginosa with integrons found in human P. aeruginosa strongly suggest a human-to-dog transfer of this IMP-45-producing isolate. Considering that (i) carbapenems are not approved for use in animals and (ii) most of the carbapenemase genes found in animals have been shown to be part of multiresistance integrons or multiresistance gene regions, 3,10 -12 co-selection and co-transfer of carbapenemase genes under the selective pressure imposed by other antimicrobial resistance genes seem to play a major role in the dissemination of carbapenemase genes. Moreover, the close contact between humans and their pet and companion animals facilitates the acquisition of carbapenem-resistant isolates of human origin by pet and companion animals. Nevertheless, surveillance of bacteria of animal origin for carbapenemase producers and prudent use of antimicrobial agents to decrease the options for co-selection of carbapenemase genes in animals are urgently warranted.
